FDA approval

Perrigo Confirms FDA Approval For Testosterone Gel 1%Perrigo Company (Nasdaq: PRGO) announced that it has received U.S. Food and Drug Administration approval for its New Drug Application for testosterone gel 1%. Perrigo's NDA included a bioequivalence study that compared its product to AbbVie's AndroGel 1%.
Stem Cell Research Aims To Help Lou Gehrig's Patients Promising new research at the University of Michigan that could bring new hope to those suffering from Lou Gehrig's disease.
Perrigo Gets FDA Approval for OTC Allergy Syrup
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen